Unlike in earlier studies, no evidence of lymphopenia or CD4 cell count reduction was observed with the islatravir component. Only 2% to 3% of patients discontinued due to adverse events ...

Maharashtra Chief Minister Devendra Fadnavis inaugurated the Mumbai Metro 3 Project's Phase 2 connecting Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli on Friday. The inauguration was ...

ORCA-3 was the second randomized, placebo-controlled Phase 3 clinical trial evaluating cytisinicline for smoking cessation in 792 U.S. adults. The authors concluded that ORCA-3 reaffirms ...

Mumbai: Mumbai is poised to open another leg of its first underground Metro, with Phase 2 of Metro Line 3 — the Aqua Line — set to become operational from Saturday, May 10. Chief Minister ...

Joe DelMauro had two goals with an assists and Owen Dunleavy added two goals for Seton Hall Prep (12-2), which led 5-1 at halftime. Clark Rich had a goal with two assists, Jack Elfstrum and Bryce ...

I look forward to helping advance the OVATION 3 trial and seeing the results.” The Phase 3 OVATION 3 trial will assess the ... with the Securities and Exchange Commission. IMUNON assumes no obligation ...

Brookfield Renewable is a leading global renewable energy and sustainable solutions company. It has a diversified portfolio of renewable assets, consisting of hydro, wind, and solar, and ...

Mark Huffman has been a consumer news reporter for ConsumerAffairs since 2004. He covers real estate, gas prices and the economy and has reported extensively on negative-option sales. He was ...

Newly minted Seahawks defensive back Nick Emmanwori will wear No. 3 with the organization this upcoming season, drawing inspiration from longtime Seattle quarterback and 10-time Pro Bowler Russell ...

With pick No. 7 in the NFL Draft, the New York Jets opted to bolster their offensive line by selecting Missouri offensive tackle Armand Membou. Membou has a lot of talent and one of the highest ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no FDA ...

Let's check out three no-brainer AI stocks to buy before earnings season gets rolling. The company has become the global leader in AI, offering the highest-performance chip around as well as a ...